![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 09, 2015 8:54:28 PM
Let's look at what's on tap for the next few weeks:
- next week is the official closing of the ESS acquisition
- the following week AMBS silver sponsor(cost $50k) to announce positive LymPro data at the AAIC
- the last week of July with the share price maintaining above $4 AMBS will qualify for NASDAQ uplist
- that will likely make IPO/uplist in early to mid August raising between $20 million - $150 million with the shelf offering
- mixed in that time frame we get first patient dosing for Eltoprazine Phase 2 trail and ESS Phase 2 trail initiating
Look at my post history, I am not one for predictions but I am gonna say the bottom is in!!
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM